Amifampridine (FIRDAPSE) 10MG tab 120/PKG NDC: 69616-0211-06
Ended Awarded Last action
- Contract number
- 36C26023F0042
- Awardee
-
Catalyst Pharmaceuticals, Inc. UEI J1B2ARLKWN53
- Awarding agency
-
Veterans Integrated Service Network 20
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $132,866
Award facts
- Contract value 100% obligated
- $132,865.82 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Coral Gables, FL 33134, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$54,886 | |
| Original award | $187,752 |
About this award
This federal contract award was issued by the Veterans Integrated Service Network 20 (VISN 20), a component of the U.S. Department of Veterans Affairs (VA), to Catalyst Pharmaceuticals, Inc. The $132,865.82 firm fixed-price delivery order was placed against Catalyst's Federal Supply Schedule (FSS-61-IB) contract for the pharmaceutical product Amifampridine (Firdapse) 10mg Tablets, which is an FDA-approved treatment for Lambert-Eaton Myasthenic Syndrome (LEMS), a rare autoimmune disorder. The contract has an ultimate completion date of October 31, 2023 and was awarded on November 1, 2022. No set-aside was used for this contract. Catalyst Pharmaceuticals, a for-profit pharmaceutical company, served as the prime contractor on this award to supply the medication to VA healthcare facilities in Florida. This delivery order is part of Catalyst's broader $920,000 FSS-61-IB contract with the VA-VHA for pharmaceutical products to support the agency's mission of providing healthcare services to veterans.
Quick answers
Who was awarded contract 36C26023F0042?
36C26023F0042 was awarded to Catalyst Pharmaceuticals, Inc. by Veterans Integrated Service Network 20 (Veterans Health Administration) on November 1, 2022.
How much is contract 36C26023F0042 worth?
The government has obligated $132,866 on 36C26023F0042.
Is contract 36C26023F0042 an order under another contract?
Yes. 36C26023F0042 is a delivery order under 36F79719D0160, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26023F0042 competed?
The extent of competition for 36C26023F0042 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award